Epigenetic Moderators of Naltrexone Efficacy for Alcohol Use Disorder
Demographics (3)
- AGE - Subject age at enrollment (phv00492208.v1.p1)
- SEX - Sex (phv00492209.v1.p1)
- SEX - Biological sex (phv00492202.v1.p1)
Mental Health (24)
- AFFECTION_STATUS - Case control status of the subject for Alcohol Use Disorder (phv00492207.v1.p1)
- DDay_1 - Drinks per day during the first 4 weeks of the treatment period (phv00492227.v1.p1)
- DDay_2 - Drinks per day during the second 4 weeks of the treatment period (phv00492228.v1.p1)
- DDay_3 - Drinks per day during the third 4 weeks of the treatment period (phv00492229.v1.p1)
- DDay_4 - Drinks per day during the last 4 weeks of the treatment period (phv00492230.v1.p1)
- DDay_B - Drinks per day in the 90 days before baseline (phv00492215.v1.p1)
- DDAYS_1 - Drinking days during the first 4 weeks of the treatment period (phv00492219.v1.p1)
- DDAYS_2 - Drinking days during the second 4 weeks of the treatment period (phv00492220.v1.p1)
- DDAYS_3 - Drinking days during the third 4 weeks of the treatment period (phv00492221.v1.p1)
- DDAYS_4 - Drinking days during the last 4 weeks of the treatment period (phv00492222.v1.p1)
- DDDay_1 - Drinks per drinking day during the first 4 weeks of the treatment period (phv00492231.v1.p1)
- DDDay_2 - Drinks per drinking day during the second 4 weeks of the treatment period (phv00492232.v1.p1)
- DDDay_3 - Drinks per drinking day during the third 4 weeks of the treatment period (phv00492233.v1.p1)
- DDDay_4 - Drinks per drinking day during the last 4 weeks of the treatment period (phv00492234.v1.p1)
- DDDay_B - Drinks per drinking day in the 90 days before baseline (phv00492216.v1.p1)
- DRINKS_1 - Total drinks during the first 4 weeks of the treatment period (phv00492223.v1.p1)
- DRINKS_2 - Total drinks during the second 4 weeks of the treatment period (phv00492224.v1.p1)
- DRINKS_3 - Total drinks during the third 4 weeks of the treatment period (phv00492225.v1.p1)
- DRINKS_4 - Total drinks during the last 4 weeks of the treatment period (phv00492226.v1.p1)
- PHDD_1 - Proportion of heavy drinking days during the first 4 weeks of the treatment period (phv00492235.v1.p1)
- PHDD_2 - Proportion of heavy drinking days during the second 4 weeks of the treatment period (phv00492236.v1.p1)
- PHDD_3 - Proportion of heavy drinking days during the third 4 weeks of the treatment period (phv00492237.v1.p1)
- PHDD_4 - Proportion of heavy drinking days during the last 4 weeks of the treatment period (phv00492238.v1.p1)
- PHDD_B - Proportion of heavy drinking days in the 90 days before baseline (phv00492218.v1.p1)
Race and Ethnicity (2)
- ETHNICITY - Self-reported ethnicity (phv00492211.v1.p1)
- RACE - Self-reported race (phv00492210.v1.p1)
Other (14)
- ANALYTE_TYPE - Analyte Type (phv00492241.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00492240.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00492201.v1.p1)
- EDUCATION - Level of education (phv00492212.v1.p1)
- EMPLOYMENT - Employment status (phv00492213.v1.p1)
- LASTDRINK - Days since last drink prior to medication randomization (phv00492214.v1.p1)
- MED_GROUP - Medication group (phv00492206.v1.p1)
- PDA_B - Proportion of days abstinent in the 90 days before baseline (phv00492217.v1.p1)
- SAMPLE_ID - Sample ID (phv00492239.v1.p1)
- SAMPLE_ID - Sample ID (phv00492204.v1.p1)
- SAMPLE_PLATE_NUMBER - Sample plate number (phv00492242.v1.p1)
- SUBJECT_ID - Subject ID (phv00492205.v1.p1)
- SUBJECT_ID - Subject ID (phv00492200.v1.p1)
- SUBJECT_ID - Subject ID (phv00492203.v1.p1)